Veracyte: Q4 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Veracyte Inc. (VCYT) on Wednesday reported a loss of $3.8 million in its fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 5 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.

The molecular diagnostic company posted revenue of $80.3 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $75.6 million.

For the year, the company reported a loss of $36.6 million, or 51 cents per share. Revenue was reported as $296.5 million.

Veracyte expects full-year revenue in the range of $325 million to $335 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on VCYT at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up